In the BioHarmony Drug Report Database
Chlorthalidone
Hygroton, Thalitone (chlorthalidone) is a small molecule pharmaceutical. Chlorthalidone was first approved as Hygroton on 1982-01-01. It is used to treat edema, glomerulonephritis, heart failure, hypertension, and liver cirrhosis amongst others in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 14, carbonic anhydrase 12, carbonic anhydrase 4, carbonic anhydrase 1, and carbonic anhydrase 2.
Trade Name
|
Hygroton, Thalitone |
|---|---|
Common Name
|
chlorthalidone |
ChEMBL ID
|
CHEMBL1055 |
Indication
|
edema, glomerulonephritis, heart failure, hypertension, liver cirrhosis, nephrotic syndrome |
Drug Class
|
Thiazide diuretic |
Image (chem structure or protein)